| 1 | newly | 4,974 |
| 2 | freshly | 261 |
| 3 | maternally | 93 |
| 4 | dually | 72 |
| 5 | recessively | 17 |
| 6 | 8187 | 9 |
| 7 | limus | 9 |
| 8 | superficies | 7 |
| 9 | 9559 | 6 |
| 10 | ultracentrifugally | 6 |
| 11 | zona-free | 6 |
| 12 | lithographically | 5 |
| 13 | trials-newly | 5 |
| 14 | sprayable | 4 |
| 15 | binomially | 3 |
| 16 | cur-nls | 3 |
| 17 | liposomally | 3 |
| 18 | 2-fluoro | 2 |
| 19 | 5,032 | 2 |
| 20 | 8681 | 2 |
| 21 | charcoals | 2 |
| 22 | circoviruses | 2 |
| 23 | confirmatively | 2 |
| 24 | crystalloid-perfused | 2 |
| 25 | epirubicin.we | 2 |
| 26 | haining | 2 |
| 27 | heat-adaptation | 2 |
| 28 | igt/ifg | 2 |
| 29 | intraurethrally | 2 |
| 30 | masterscreen | 2 |
| 31 | newly- | 2 |
| 32 | non-directionally | 2 |
| 33 | non-thalassemia | 2 |
| 34 | oligostilbenes | 2 |
| 35 | one-dimensionally | 2 |
| 36 | paraprofessionally | 2 |
| 37 | postglacially | 2 |
| 38 | propiolonitriles | 2 |
| 39 | receptor/channels | 2 |
| 40 | sequence-characterized | 2 |
| 41 | shock-electrodes | 2 |
| 42 | teleologically | 2 |
| 43 | 'newly | 1 |
| 44 | 'recently | 1 |
| 45 | -5117 | 1 |
| 46 | 1,4-phenanthraquinone | 1 |
| 47 | 1-bromoalkoxyalkanes | 1 |
| 48 | 10-to-15-minute | 1 |
| 49 | 10098 | 1 |
| 50 | 107,749 | 1 |
| 51 | 10q26-qter | 1 |
| 52 | 13,566 | 1 |
| 53 | 1h-indol-1-yl | 1 |
| 54 | 2-bromoenals | 1 |
| 55 | 2-pyridylhydrazones | 1 |
| 56 | 22,182 | 1 |
| 57 | 3,4-dihydronaphthalene | 1 |
| 58 | 3,486 | 1 |
| 59 | 3-methyl-substituent | 1 |
| 60 | 3-o-desulfation | 1 |
| 61 | 34,523 | 1 |
| 62 | 41-site | 1 |
| 63 | 46-year-old-male | 1 |
| 64 | 524-bp | 1 |
| 65 | 59,672 | 1 |
| 66 | 6,450 | 1 |
| 67 | 6137 | 1 |
| 68 | 696,118 | 1 |
| 69 | 7,686 | 1 |
| 70 | 70,633 | 1 |
| 71 | 77284 | 1 |
| 72 | 77se | 1 |
| 73 | 8,5'-cyclo-2'-deoxyguanosine | 1 |
| 74 | 9-aa | 1 |
| 75 | 930,997 | 1 |
| 76 | :phac1 | 1 |
| 77 | actomysin | 1 |
| 78 | administration.we | 1 |
| 79 | alkanedithiol | 1 |
| 80 | amino-oxazoles | 1 |
| 81 | angolans | 1 |
| 82 | antenately | 1 |
| 83 | anti-mir-122 | 1 |
| 84 | arbortristoside-a | 1 |
| 85 | archeaon | 1 |
| 86 | aryloxy-1,3,4-thiadiazoles | 1 |
| 87 | austria.we | 1 |
| 88 | bcu24 | 1 |
| 89 | bevacizuamb | 1 |
| 90 | bilinearly | 1 |
| 91 | biogenically | 1 |
| 92 | biotechnically | 1 |
| 93 | budesonide/salbutamol | 1 |
| 94 | cancer.patients | 1 |
| 95 | candibioic | 1 |
| 96 | cardiofibrolasts | 1 |
| 97 | center/global | 1 |
| 98 | chemosenor | 1 |
| 99 | chorionamnionitis | 1 |
| 100 | coeloms | 1 |
| 101 | complexes/adhesives | 1 |
| 102 | control-sirna | 1 |
| 103 | counterscreen | 1 |
| 104 | custom- | 1 |
| 105 | cyanocobalamin-a | 1 |
| 106 | cytokine/chemokines | 1 |
| 107 | d-arabinose | 1 |
| 108 | dialkenylhydroxylamines | 1 |
| 109 | dre-treated | 1 |
| 110 | dtpa/dmsa | 1 |
| 111 | duplicate.we | 1 |
| 112 | dvt-alone | 1 |
| 113 | dyskeratocytes | 1 |
| 114 | déjà-vu | 1 |
| 115 | england-were | 1 |
| 116 | eortc-bccg | 1 |
| 117 | erinacines | 1 |
| 118 | erlotinib/gemcitabine | 1 |
| 119 | es-complex | 1 |
| 120 | exogeneously | 1 |
| 121 | exudations | 1 |
| 122 | fdca | 1 |
| 123 | gcs.most | 1 |
| 124 | gel/foam | 1 |
| 125 | genitally | 1 |
| 126 | heated-sperm | 1 |
| 127 | heidegger | 1 |
| 128 | hematopoietically | 1 |
| 129 | hemicellulose-decomposing | 1 |
| 130 | hmts | 1 |
| 131 | hot-extracts | 1 |
| 132 | hypomagnesemia-exhibiting | 1 |
| 133 | ibv-on5 | 1 |
| 134 | ic3 | 1 |
| 135 | iminoesters | 1 |
| 136 | interest.the | 1 |
| 137 | its1/its5.8r | 1 |
| 138 | kasanin | 1 |
| 139 | koos5 | 1 |
| 140 | kovach | 1 |
| 141 | letters-to-the-editor | 1 |
| 142 | life.infants | 1 |
| 143 | li₂o | 1 |
| 144 | lysogens | 1 |
| 145 | metabolites-were | 1 |
| 146 | metabonate | 1 |
| 147 | metalloenamine | 1 |
| 148 | methoxycinnamate-npsuns | 1 |
| 149 | michaelseni | 1 |
| 150 | microactuators | 1 |
| 151 | microvilosities | 1 |
| 152 | minocycline.the | 1 |
| 153 | morinthone | 1 |
| 154 | most-frequent | 1 |
| 155 | mouse-brain | 1 |
| 156 | multi-remotely | 1 |
| 157 | n'angus | 1 |
| 158 | n-methyl/phenylpiperazine | 1 |
| 159 | nanoadsorbents | 1 |
| 160 | nanointerfaces | 1 |
| 161 | nanozeolites | 1 |
| 162 | neuro-hormone | 1 |
| 163 | neuro-peptide | 1 |
| 164 | neuropterida | 1 |
| 165 | neutral–neutral | 1 |
| 166 | nights.the | 1 |
| 167 | non-travel-related | 1 |
| 168 | noncom-pleters | 1 |
| 169 | noradrenaline-contracted | 1 |
| 170 | nqaif311 | 1 |
| 171 | nthsp18.2/nthsp18.3 | 1 |
| 172 | nurse-therapist | 1 |
| 173 | opioids.the | 1 |
| 174 | origin.the | 1 |
| 175 | osteoporotics | 1 |
| 176 | p74-26 | 1 |
| 177 | pasha | 1 |
| 178 | pentacyclic-triterpene | 1 |
| 179 | pentobarbitone-morphine | 1 |
| 180 | pf-ph | 1 |
| 181 | physician-epidemiologists | 1 |
| 182 | pklr | 1 |
| 183 | plakins | 1 |
| 184 | point-face | 1 |
| 185 | pole-stub | 1 |
| 186 | polyazamacrocycle | 1 |
| 187 | polyhydroxyflavone | 1 |
| 188 | ppar-agonist | 1 |
| 189 | pre-questionnaires | 1 |
| 190 | prenataly | 1 |
| 191 | prognosis.those | 1 |
| 192 | prospectly | 1 |
| 193 | publication.we | 1 |
| 194 | q-mi | 1 |
| 195 | qth-curing | 1 |
| 196 | quantum-chemically | 1 |
| 197 | quercetin-3,7-o-alpha-dirhamnoside | 1 |
| 198 | raloxifene-6-glucuronide | 1 |
| 199 | rd207 | 1 |
| 200 | respiratology | 1 |
| 201 | retrocavities | 1 |
| 202 | ring-nanostructures | 1 |
| 203 | rsv-pneumonia | 1 |
| 204 | rt-pcrs | 1 |
| 205 | sadps | 1 |
| 206 | safelac | 1 |
| 207 | semi-empirically | 1 |
| 208 | seritide | 1 |
| 209 | sil-slns | 1 |
| 210 | silkdb | 1 |
| 211 | sites/services | 1 |
| 212 | six-frame | 1 |
| 213 | subsurface-flow | 1 |
| 214 | tetrahydrofuran-2-carboxamides | 1 |
| 215 | th-npg-gn | 1 |
| 216 | tri-n-butylborane | 1 |
| 217 | triplot | 1 |
| 218 | ultra-athletes | 1 |
| 219 | unigeneswere | 1 |
| 220 | veiligheidnl | 1 |
| 221 | video-cameras | 1 |
| 222 | visits-as | 1 |
| 223 | β-1,3/1,6-glucans | 1 |
| 224 | β-aminophosphines | 1 |
| 225 | ≥21years | 1 |
| 1 | 'newly | 1 |
| 2 | 'recently | 1 |
| 3 | -5117 | 1 |
| 4 | 1,4-phenanthraquinone | 1 |
| 5 | 1-bromoalkoxyalkanes | 1 |
| 6 | 10-to-15-minute | 1 |
| 7 | 10098 | 1 |
| 8 | 107,749 | 1 |
| 9 | 10q26-qter | 1 |
| 10 | 13,566 | 1 |
| 11 | 1h-indol-1-yl | 1 |
| 12 | 2-bromoenals | 1 |
| 13 | 2-fluoro | 2 |
| 14 | 2-pyridylhydrazones | 1 |
| 15 | 22,182 | 1 |
| 16 | 3,4-dihydronaphthalene | 1 |
| 17 | 3,486 | 1 |
| 18 | 3-methyl-substituent | 1 |
| 19 | 3-o-desulfation | 1 |
| 20 | 34,523 | 1 |
| 21 | 41-site | 1 |
| 22 | 46-year-old-male | 1 |
| 23 | 5,032 | 2 |
| 24 | 524-bp | 1 |
| 25 | 59,672 | 1 |
| 26 | 6,450 | 1 |
| 27 | 6137 | 1 |
| 28 | 696,118 | 1 |
| 29 | 7,686 | 1 |
| 30 | 70,633 | 1 |
| 31 | 77284 | 1 |
| 32 | 77se | 1 |
| 33 | 8,5'-cyclo-2'-deoxyguanosine | 1 |
| 34 | 8187 | 9 |
| 35 | 8681 | 2 |
| 36 | 9-aa | 1 |
| 37 | 930,997 | 1 |
| 38 | 9559 | 6 |
| 39 | :phac1 | 1 |
| 40 | actomysin | 1 |
| 41 | administration.we | 1 |
| 42 | alkanedithiol | 1 |
| 43 | amino-oxazoles | 1 |
| 44 | angolans | 1 |
| 45 | antenately | 1 |
| 46 | anti-mir-122 | 1 |
| 47 | arbortristoside-a | 1 |
| 48 | archeaon | 1 |
| 49 | aryloxy-1,3,4-thiadiazoles | 1 |
| 50 | austria.we | 1 |
| 51 | bcu24 | 1 |
| 52 | bevacizuamb | 1 |
| 53 | bilinearly | 1 |
| 54 | binomially | 3 |
| 55 | biogenically | 1 |
| 56 | biotechnically | 1 |
| 57 | budesonide/salbutamol | 1 |
| 58 | cancer.patients | 1 |
| 59 | candibioic | 1 |
| 60 | cardiofibrolasts | 1 |
| 61 | center/global | 1 |
| 62 | charcoals | 2 |
| 63 | chemosenor | 1 |
| 64 | chorionamnionitis | 1 |
| 65 | circoviruses | 2 |
| 66 | coeloms | 1 |
| 67 | complexes/adhesives | 1 |
| 68 | confirmatively | 2 |
| 69 | control-sirna | 1 |
| 70 | counterscreen | 1 |
| 71 | crystalloid-perfused | 2 |
| 72 | cur-nls | 3 |
| 73 | custom- | 1 |
| 74 | cyanocobalamin-a | 1 |
| 75 | cytokine/chemokines | 1 |
| 76 | d-arabinose | 1 |
| 77 | dialkenylhydroxylamines | 1 |
| 78 | dre-treated | 1 |
| 79 | dtpa/dmsa | 1 |
| 80 | dually | 72 |
| 81 | duplicate.we | 1 |
| 82 | dvt-alone | 1 |
| 83 | dyskeratocytes | 1 |
| 84 | déjà-vu | 1 |
| 85 | england-were | 1 |
| 86 | eortc-bccg | 1 |
| 87 | epirubicin.we | 2 |
| 88 | erinacines | 1 |
| 89 | erlotinib/gemcitabine | 1 |
| 90 | es-complex | 1 |
| 91 | exogeneously | 1 |
| 92 | exudations | 1 |
| 93 | fdca | 1 |
| 94 | freshly | 261 |
| 95 | gcs.most | 1 |
| 96 | gel/foam | 1 |
| 97 | genitally | 1 |
| 98 | haining | 2 |
| 99 | heat-adaptation | 2 |
| 100 | heated-sperm | 1 |
| 101 | heidegger | 1 |
| 102 | hematopoietically | 1 |
| 103 | hemicellulose-decomposing | 1 |
| 104 | hmts | 1 |
| 105 | hot-extracts | 1 |
| 106 | hypomagnesemia-exhibiting | 1 |
| 107 | ibv-on5 | 1 |
| 108 | ic3 | 1 |
| 109 | igt/ifg | 2 |
| 110 | iminoesters | 1 |
| 111 | interest.the | 1 |
| 112 | intraurethrally | 2 |
| 113 | its1/its5.8r | 1 |
| 114 | kasanin | 1 |
| 115 | koos5 | 1 |
| 116 | kovach | 1 |
| 117 | letters-to-the-editor | 1 |
| 118 | life.infants | 1 |
| 119 | limus | 9 |
| 120 | liposomally | 3 |
| 121 | lithographically | 5 |
| 122 | li₂o | 1 |
| 123 | lysogens | 1 |
| 124 | masterscreen | 2 |
| 125 | maternally | 93 |
| 126 | metabolites-were | 1 |
| 127 | metabonate | 1 |
| 128 | metalloenamine | 1 |
| 129 | methoxycinnamate-npsuns | 1 |
| 130 | michaelseni | 1 |
| 131 | microactuators | 1 |
| 132 | microvilosities | 1 |
| 133 | minocycline.the | 1 |
| 134 | morinthone | 1 |
| 135 | most-frequent | 1 |
| 136 | mouse-brain | 1 |
| 137 | multi-remotely | 1 |
| 138 | n'angus | 1 |
| 139 | n-methyl/phenylpiperazine | 1 |
| 140 | nanoadsorbents | 1 |
| 141 | nanointerfaces | 1 |
| 142 | nanozeolites | 1 |
| 143 | neuro-hormone | 1 |
| 144 | neuro-peptide | 1 |
| 145 | neuropterida | 1 |
| 146 | neutral–neutral | 1 |
| 147 | newly | 4,974 |
| 148 | newly- | 2 |
| 149 | nights.the | 1 |
| 150 | non-directionally | 2 |
| 151 | non-thalassemia | 2 |
| 152 | non-travel-related | 1 |
| 153 | noncom-pleters | 1 |
| 154 | noradrenaline-contracted | 1 |
| 155 | nqaif311 | 1 |
| 156 | nthsp18.2/nthsp18.3 | 1 |
| 157 | nurse-therapist | 1 |
| 158 | oligostilbenes | 2 |
| 159 | one-dimensionally | 2 |
| 160 | opioids.the | 1 |
| 161 | origin.the | 1 |
| 162 | osteoporotics | 1 |
| 163 | p74-26 | 1 |
| 164 | paraprofessionally | 2 |
| 165 | pasha | 1 |
| 166 | pentacyclic-triterpene | 1 |
| 167 | pentobarbitone-morphine | 1 |
| 168 | pf-ph | 1 |
| 169 | physician-epidemiologists | 1 |
| 170 | pklr | 1 |
| 171 | plakins | 1 |
| 172 | point-face | 1 |
| 173 | pole-stub | 1 |
| 174 | polyazamacrocycle | 1 |
| 175 | polyhydroxyflavone | 1 |
| 176 | postglacially | 2 |
| 177 | ppar-agonist | 1 |
| 178 | pre-questionnaires | 1 |
| 179 | prenataly | 1 |
| 180 | prognosis.those | 1 |
| 181 | propiolonitriles | 2 |
| 182 | prospectly | 1 |
| 183 | publication.we | 1 |
| 184 | q-mi | 1 |
| 185 | qth-curing | 1 |
| 186 | quantum-chemically | 1 |
| 187 | quercetin-3,7-o-alpha-dirhamnoside | 1 |
| 188 | raloxifene-6-glucuronide | 1 |
| 189 | rd207 | 1 |
| 190 | receptor/channels | 2 |
| 191 | recessively | 17 |
| 192 | respiratology | 1 |
| 193 | retrocavities | 1 |
| 194 | ring-nanostructures | 1 |
| 195 | rsv-pneumonia | 1 |
| 196 | rt-pcrs | 1 |
| 197 | sadps | 1 |
| 198 | safelac | 1 |
| 199 | semi-empirically | 1 |
| 200 | sequence-characterized | 2 |
| 201 | seritide | 1 |
| 202 | shock-electrodes | 2 |
| 203 | sil-slns | 1 |
| 204 | silkdb | 1 |
| 205 | sites/services | 1 |
| 206 | six-frame | 1 |
| 207 | sprayable | 4 |
| 208 | subsurface-flow | 1 |
| 209 | superficies | 7 |
| 210 | teleologically | 2 |
| 211 | tetrahydrofuran-2-carboxamides | 1 |
| 212 | th-npg-gn | 1 |
| 213 | tri-n-butylborane | 1 |
| 214 | trials-newly | 5 |
| 215 | triplot | 1 |
| 216 | ultra-athletes | 1 |
| 217 | ultracentrifugally | 6 |
| 218 | unigeneswere | 1 |
| 219 | veiligheidnl | 1 |
| 220 | video-cameras | 1 |
| 221 | visits-as | 1 |
| 222 | zona-free | 6 |
| 223 | β-1,3/1,6-glucans | 1 |
| 224 | β-aminophosphines | 1 |
| 225 | ≥21years | 1 |
| 1 | custom- | 1 |
| 2 | newly- | 2 |
| 3 | 6,450 | 1 |
| 4 | nqaif311 | 1 |
| 5 | 8681 | 2 |
| 6 | :phac1 | 1 |
| 7 | anti-mir-122 | 1 |
| 8 | 5,032 | 2 |
| 9 | 59,672 | 1 |
| 10 | 22,182 | 1 |
| 11 | nthsp18.2/nthsp18.3 | 1 |
| 12 | 34,523 | 1 |
| 13 | 70,633 | 1 |
| 14 | ic3 | 1 |
| 15 | bcu24 | 1 |
| 16 | 77284 | 1 |
| 17 | ibv-on5 | 1 |
| 18 | koos5 | 1 |
| 19 | p74-26 | 1 |
| 20 | 13,566 | 1 |
| 21 | 3,486 | 1 |
| 22 | 7,686 | 1 |
| 23 | rd207 | 1 |
| 24 | -5117 | 1 |
| 25 | 6137 | 1 |
| 26 | 8187 | 9 |
| 27 | 930,997 | 1 |
| 28 | 696,118 | 1 |
| 29 | 10098 | 1 |
| 30 | 107,749 | 1 |
| 31 | 9559 | 6 |
| 32 | arbortristoside-a | 1 |
| 33 | cyanocobalamin-a | 1 |
| 34 | 9-aa | 1 |
| 35 | fdca | 1 |
| 36 | neuropterida | 1 |
| 37 | pasha | 1 |
| 38 | non-thalassemia | 2 |
| 39 | rsv-pneumonia | 1 |
| 40 | control-sirna | 1 |
| 41 | dtpa/dmsa | 1 |
| 42 | silkdb | 1 |
| 43 | bevacizuamb | 1 |
| 44 | pole-stub | 1 |
| 45 | safelac | 1 |
| 46 | candibioic | 1 |
| 47 | crystalloid-perfused | 2 |
| 48 | dre-treated | 1 |
| 49 | non-travel-related | 1 |
| 50 | noradrenaline-contracted | 1 |
| 51 | sequence-characterized | 2 |
| 52 | point-face | 1 |
| 53 | raloxifene-6-glucuronide | 1 |
| 54 | quercetin-3,7-o-alpha-dirhamnoside | 1 |
| 55 | seritide | 1 |
| 56 | neuro-peptide | 1 |
| 57 | zona-free | 6 |
| 58 | minocycline.the | 1 |
| 59 | origin.the | 1 |
| 60 | opioids.the | 1 |
| 61 | nights.the | 1 |
| 62 | interest.the | 1 |
| 63 | 46-year-old-male | 1 |
| 64 | sprayable | 4 |
| 65 | polyazamacrocycle | 1 |
| 66 | six-frame | 1 |
| 67 | tri-n-butylborane | 1 |
| 68 | 3,4-dihydronaphthalene | 1 |
| 69 | pentacyclic-triterpene | 1 |
| 70 | erlotinib/gemcitabine | 1 |
| 71 | pentobarbitone-morphine | 1 |
| 72 | metalloenamine | 1 |
| 73 | 8,5'-cyclo-2'-deoxyguanosine | 1 |
| 74 | n-methyl/phenylpiperazine | 1 |
| 75 | morinthone | 1 |
| 76 | dvt-alone | 1 |
| 77 | neuro-hormone | 1 |
| 78 | 1,4-phenanthraquinone | 1 |
| 79 | polyhydroxyflavone | 1 |
| 80 | england-were | 1 |
| 81 | metabolites-were | 1 |
| 82 | unigeneswere | 1 |
| 83 | 77se | 1 |
| 84 | prognosis.those | 1 |
| 85 | d-arabinose | 1 |
| 86 | metabonate | 1 |
| 87 | 41-site | 1 |
| 88 | 10-to-15-minute | 1 |
| 89 | austria.we | 1 |
| 90 | duplicate.we | 1 |
| 91 | epirubicin.we | 2 |
| 92 | publication.we | 1 |
| 93 | administration.we | 1 |
| 94 | eortc-bccg | 1 |
| 95 | igt/ifg | 2 |
| 96 | haining | 2 |
| 97 | qth-curing | 1 |
| 98 | hemicellulose-decomposing | 1 |
| 99 | hypomagnesemia-exhibiting | 1 |
| 100 | kovach | 1 |
| 101 | pf-ph | 1 |
| 102 | q-mi | 1 |
| 103 | michaelseni | 1 |
| 104 | center/global | 1 |
| 105 | neutral–neutral | 1 |
| 106 | veiligheidnl | 1 |
| 107 | alkanedithiol | 1 |
| 108 | budesonide/salbutamol | 1 |
| 109 | 1h-indol-1-yl | 1 |
| 110 | gel/foam | 1 |
| 111 | heated-sperm | 1 |
| 112 | counterscreen | 1 |
| 113 | masterscreen | 2 |
| 114 | th-npg-gn | 1 |
| 115 | mouse-brain | 1 |
| 116 | kasanin | 1 |
| 117 | actomysin | 1 |
| 118 | archeaon | 1 |
| 119 | 3-o-desulfation | 1 |
| 120 | heat-adaptation | 2 |
| 121 | 2-fluoro | 2 |
| 122 | li₂o | 1 |
| 123 | 524-bp | 1 |
| 124 | its1/its5.8r | 1 |
| 125 | heidegger | 1 |
| 126 | 10q26-qter | 1 |
| 127 | pklr | 1 |
| 128 | chemosenor | 1 |
| 129 | letters-to-the-editor | 1 |
| 130 | visits-as | 1 |
| 131 | video-cameras | 1 |
| 132 | osteoporotics | 1 |
| 133 | nanointerfaces | 1 |
| 134 | sites/services | 1 |
| 135 | tetrahydrofuran-2-carboxamides | 1 |
| 136 | shock-electrodes | 2 |
| 137 | superficies | 7 |
| 138 | microvilosities | 1 |
| 139 | retrocavities | 1 |
| 140 | propiolonitriles | 2 |
| 141 | aryloxy-1,3,4-thiadiazoles | 1 |
| 142 | amino-oxazoles | 1 |
| 143 | 1-bromoalkoxyalkanes | 1 |
| 144 | oligostilbenes | 2 |
| 145 | erinacines | 1 |
| 146 | β-aminophosphines | 1 |
| 147 | cytokine/chemokines | 1 |
| 148 | dialkenylhydroxylamines | 1 |
| 149 | 2-pyridylhydrazones | 1 |
| 150 | pre-questionnaires | 1 |
| 151 | ring-nanostructures | 1 |
| 152 | circoviruses | 2 |
| 153 | ultra-athletes | 1 |
| 154 | nanozeolites | 1 |
| 155 | dyskeratocytes | 1 |
| 156 | complexes/adhesives | 1 |
| 157 | chorionamnionitis | 1 |
| 158 | 2-bromoenals | 1 |
| 159 | charcoals | 2 |
| 160 | receptor/channels | 2 |
| 161 | cur-nls | 3 |
| 162 | coeloms | 1 |
| 163 | β-1,3/1,6-glucans | 1 |
| 164 | angolans | 1 |
| 165 | lysogens | 1 |
| 166 | plakins | 1 |
| 167 | sil-slns | 1 |
| 168 | exudations | 1 |
| 169 | methoxycinnamate-npsuns | 1 |
| 170 | sadps | 1 |
| 171 | ≥21years | 1 |
| 172 | rt-pcrs | 1 |
| 173 | noncom-pleters | 1 |
| 174 | iminoesters | 1 |
| 175 | microactuators | 1 |
| 176 | hot-extracts | 1 |
| 177 | hmts | 1 |
| 178 | life.infants | 1 |
| 179 | nanoadsorbents | 1 |
| 180 | cancer.patients | 1 |
| 181 | cardiofibrolasts | 1 |
| 182 | physician-epidemiologists | 1 |
| 183 | n'angus | 1 |
| 184 | limus | 9 |
| 185 | most-frequent | 1 |
| 186 | 3-methyl-substituent | 1 |
| 187 | triplot | 1 |
| 188 | ppar-agonist | 1 |
| 189 | nurse-therapist | 1 |
| 190 | gcs.most | 1 |
| 191 | déjà-vu | 1 |
| 192 | subsurface-flow | 1 |
| 193 | es-complex | 1 |
| 194 | respiratology | 1 |
| 195 | prenataly | 1 |
| 196 | antenately | 1 |
| 197 | multi-remotely | 1 |
| 198 | recessively | 17 |
| 199 | confirmatively | 2 |
| 200 | freshly | 261 |
| 201 | teleologically | 2 |
| 202 | lithographically | 5 |
| 203 | quantum-chemically | 1 |
| 204 | biogenically | 1 |
| 205 | biotechnically | 1 |
| 206 | semi-empirically | 1 |
| 207 | hematopoietically | 1 |
| 208 | ultracentrifugally | 6 |
| 209 | postglacially | 2 |
| 210 | binomially | 3 |
| 211 | liposomally | 3 |
| 212 | one-dimensionally | 2 |
| 213 | paraprofessionally | 2 |
| 214 | non-directionally | 2 |
| 215 | maternally | 93 |
| 216 | intraurethrally | 2 |
| 217 | genitally | 1 |
| 218 | dually | 72 |
| 219 | bilinearly | 1 |
| 220 | exogeneously | 1 |
| 221 | prospectly | 1 |
| 222 | 'recently | 1 |
| 223 | newly | 4,974 |
| 224 | 'newly | 1 |
| 225 | trials-newly | 5 |